2024/09/26 17:32:23 | |
---|---|
Price | |
62.50 EUR | |
Difference | 0.55% (0.34) |
ISIN | US09061G1013 |
Symbol | BMRN |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 12,015 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 62.72 EUR |
High | 62.82 EUR |
Low | 62.16 EUR |
Close (prev. day) | 62.16 EUR |
VWAP | 62.36 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/26 17:32:23 | |
---|---|
Price | |
62.50 EUR | |
Difference | 0.55% (0.34) |
ISIN | US09061G1013 |
Symbol | BMRN |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 12,015 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 62.72 EUR |
High | 62.82 EUR |
Low | 62.16 EUR |
Close (prev. day) | 62.16 EUR |
VWAP | 62.36 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 5 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -22.32% | -24.54% | -6.74% |
Perf (abs.) | -17.96 | -20.32 | -4.52 |
Beta | 0.59 | 0.60 | 0.72 |
Volatility | 42.19 | 35.56 | 32.42 |
Ø price 5 days | Ø volume 5 days (pcs.) | 62.56 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 75.11 EUR (6) |
Ø price 100 days | Ø volume 100 days (pcs.) | 75.86 EUR (11) |
Ø price 250 days | Ø volume 250 days (pcs.) | 79.56 EUR (9) |
YTD High | date | 90.16 EUR (2024/01/09) |
YTD Low | date | 61.28 EUR (2024/09/24) |
52 Weeks High | date | 90.16 EUR (2024/01/09) |
52 Weeks Low | date | 61.28 EUR (2024/09/24) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/11/24 | 17:35 | 81.02 EUR | 0.00 | 2 |
Vienna Stock Exchange | 2024/09/26 | 17:32 | 62.50 EUR | 0.00 | 5 |
Tradegate | 2024/09/26 | 22:26 | 62.82 EUR | 0.01 | 4 |
Stuttgart | 2024/09/26 | 21:31 | 62.40 EUR | 0.00 | 4 |
Nasdaq | 2024/09/26 | 22:00 | 70.24 USD | 91.30 | 19,942 |
Munich | 2024/09/26 | 08:00 | 62.22 EUR | 0.00 | 2 |
London Stock Exchange | 2024/09/25 | 15:32 | 69.45 USD | 0.00 | 2 |
Hanover | 2024/09/26 | 17:25 | 62.52 EUR | 0.00 | 4 |
Frankfurt | 2024/09/26 | 15:31 | 62.34 EUR | 0.00 | 1 |
Euronext Milan MTF Trading After Hours | - | - | - | 0.00 | - |
Euronext Milan MTF Global Equity Market | 2024/09/26 | 17:44 | 62.54 EUR | 0.00 | 1 |
Duesseldorf | 2024/09/26 | 19:31 | 62.44 EUR | 0.00 | 7 |
Berlin | 2024/09/26 | 08:08 | 62.42 EUR | 0.00 | 3 |
BIOMARIN PHARMACEUTICAL INC. |
- - |
371 Bel Marin Keys Blvd., Suite 210 CA 94949 Novato |
Telefon: (415) 884-6700 |
Fax: (415) 382-7889 |
E-mail: webmaster@biomarinpharm.com |
- |
Richard Meier | Chairman of Board of Directors |
Athena Countouriotis | Member of Board of Directors |
Dennis Slamon | Member of Board of Directors |
Elaine Heron | Member of Board of Directors |
May Kin Ho | Member of Board of Directors |
V. Lawlis | Member of Board of Directors |
Willard Dere | Member of Board of Directors |
Barbara Bodem | Member of Board of Directors |
David Pyott | Member of Board of Directors |
Elizabeth Anderson | Member of Board of Directors |
Jean-Jacques Bienaimé | Member of Board of Directors |
Mark Alles | Member of Board of Directors |
Mark Enyedy | Member of Board of Directors |
Robert Hombach | Member of Board of Directors |
Jean-Jacques Bienaimé | Chairman of Managing Board |
Brinda Balakrishnan | Member of Executive Committee |
C. Greg Guyer | Member of Executive Committee |
Amy Wireman | Member of Executive Committee |
Brian Mueller | Member of Executive Committee |
G. Eric Davis | Member of Executive Committee |
Henry J. Fuchs | Member of Executive Committee |
Jeff Ajer | Member of Executive Committee |
Philip Lo Scalzo | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer